By Siddhi Mahatole and Puyaan Singh July 7 (Reuters) - The U.S. Food and Drug Administration said on Tuesday it had approved ...
Chronic kidney disease (CKD) is common, largely silent, and serious. Most people who have the condition do not realize they ...
Finerenone shows promise in slowing chronic kidney disease progression in non-diabetic patients, according to recent global ...
MedPage Today on MSN
Chronic kidney disease increasingly driven by diabetes
Despite treatment advances, kidney disease burden remained unchanged over the past decade ...
Paul Makulinski, a firefighter and EMT, celebrates a "second chance at life" after a life-saving kidney transplant on his ...
Vera Therapeutics said the U.S. Food and Drug Administration granted accelerated approval for Trutakna to reduce proteinuria, or protein in urine, for adults with primary IgA nephropathy who are at ...
Preview this article 1 min Trutakna — a once-a-week, self-injected drug — could carry a wholesale price of nearly $400,000 a ...
Shares of Vera Therapeutics rose about 8% Tuesday after the Food and Drug Administration approved its treatment for a kidney ...
Vera Therapeutics' Trutakna received an early, fast-tracked approval from the FDA to reduce proteinuria in adults with ...
The clearance marks another step forward in treatment for IgA nephropathy and sets up a commercial battle with Otsuka, which ...
Women diagnosed early in pregnancy with a fetus lacking adequate kidney function to make the urine that serves as vital ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results